Australia markets closed

Kezar Life Sciences, Inc. (KZR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.6940+0.0096 (+1.40%)
At close: 04:00PM EDT
0.7200 +0.03 (+3.75%)
After hours: 06:22PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
35,493
40,456
62,882
21,228
-
Other short-term investments
165,879
236,105
145,473
119,219
-
Total cash
201,372
276,561
208,355
140,447
-
Other current assets
-
920
729
1,631
1,048
Total current assets
206,950
285,722
211,654
144,811
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
14,110
17,774
9,649
9,491
-
Accumulated depreciation
-5,420
-4,602
-3,652
-2,742
-
Net property, plant and equipment
8,690
13,172
5,997
6,749
-
Other long-term assets
5,595
674
282
282
-
Total non-current assets
14,285
13,846
6,279
7,031
-
Total assets
221,235
299,568
217,933
151,842
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
8,251
2,479
2,028
2,358
-
Accrued liabilities
2,667
2,428
2,916
1,493
-
Other current liabilities
106
265
99
194
-
Total current liabilities
17,744
10,997
8,212
6,442
-
Non-current liabilities
Long-term debt
10,069
9,834
9,622
-
-
Total non-current liabilities
15,921
18,699
12,845
4,422
-
Total liabilities
33,665
29,696
21,057
10,864
-
Stockholders' equity
Common stock
73
68
56
46
-
Retained earnings
-350,763
-248,893
-180,654
-126,024
-
Accumulated other comprehensive income
-130
-923
-291
-137
-
Total stockholders' equity
187,570
269,872
196,876
140,978
-
Total liabilities and stockholders' equity
221,235
299,568
217,933
151,842
-